--- title: 'Sr. Scientist, Discovery Biology at Superluminal Medicines, Inc.' canonical: 'https://feeny.ai/job/sr-scientist-discovery-biology-superluminal-medicines-inc-boston-16yz8snbevdt' type: 'job' last_seen: '2026-10-14' --- # Sr. Scientist, Discovery Biology at Superluminal Medicines, Inc. - **Company:** Superluminal Medicines, Inc. - **Location:** Boston, MA - **Posted:** 2026-09-28 - **Last confirmed live:** 2026-10-14 - **Apply:** https://job-boards.greenhouse.io/superluminalrx/jobs/5435267008 ## Job description About Superluminal Medicines: Superluminal Medicines is a generative biology and chemistry company revolutionizing the speed and accuracy of how small molecule medicines are created. The Company’s platform aims to create candidate-ready compounds with unprecedented speed using a combination of deep biology, computational and medicinal chemistry, machine learning, and proprietary big data infrastructure. We are expanding the team of talented scientists who seek to build the future of small molecule drug discovery with creativity and innovation. About the Role: We are seeking a highly motivated and experienced drug discovery biologist join our growing Discovery Biology team. The successful candidate brings significant hands-on expertise in cell-based assay development and enablement to drive early drug discovery programs. The candidate will lead from the bench and contribute to biology strategy and execution across Superluminal programs. Must be able to work onsite five days a week. Key Responsibilities: - This role is hands-on and wet lab-focused to drive programs from hit finding through all phases of early discovery. - Independently design, develop and execute a broad array of cell-based assays to interrogate GPCR function and signaling. - Generate, analyze, document, and upload experimental and routine screening data to company databases in a timely and accurate manner. - Collaborate cross-functionally with computational, chemistry and protein science colleagues to conceptualize, design, and execute novel screening assays. - Regularly communicate findings with program teams and present at project & company-wide meetings. - Ensure compliance with established laboratory practices, SOPs, and company policies, including both wet lab and electronic data management requirements. ## Minimum Qualifications - Ph.D. in Biology or a related life sciences field, with 5 or more years of relevant industry experience. - Demonstrated hands-on experience developing, executing, and interpreting cell-based assays using multiple assay formats and platforms, including functional assays, target engagement assays, kinetic assays, plate-based assays, flow cytometry, and high-content imaging. - Small molecule drug discovery experience required. - Demonstrated problem-solving skills and ability to develop innovative solutions to complex challenges. Preferred Qualifications: - Experience with GPCR biology is highly desired. - Experience with assay automation, high-throughput screening, or laboratory robotics is a plus. - Management experience is a plus. Pay Range $150,000 - $176,000 The annual base salary range listed above represents the lowest and highest amounts we reasonably and in good faith expect to pay for this position at the time of posting. An individual’s starting base salary within this range will be based on relevant experience, job-related skills, and education relevant to the role. In addition to base salary, this position offers bonus and equity opportunities, as well as benefits. Benefits: Superluminal offers a comprehensive benefits package that fully covers employees’ annual deductibles and monthly premiums for medical, dental, and vision insurance. The package also includes a 401(k) match program, a Massachusetts transportation subsidy, equity, unlimited paid time off, and both disability and life insurance. Equal Opportunity Statement: Superluminal Medicines is an Equal Opportunity Employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status. ## About Superluminal Medicines, Inc. ## Company Overview - **One-liner**: Superluminal Medicines is a drug discovery company integrating AI/ML, protein dynamics, and structural biology to rapidly develop small molecule therapeutics targeting challenging G protein-coupled receptors (GPCRs) for cardiometabolic diseases and obesity. - **Entity Type**: Private (Convertible Note financing round; total funding $158M as of 2026) - **Headquarters**: Boston, Massachusetts, United States (15 Necco Street, 4th Floor) - **Founded**: 2022 - **Founders**: Not publicly disclosed ## Core Business - **Primary Industry**: Biotechnology / Drug Discovery & Development - **Target Customers**: B2B partnerships with large pharmaceutical companies (e.g., Eli Lilly) and, ultimately, patients with cardiometabolic conditions and obesity - **Mission / Purpose**: “Revolutionizing the speed and accuracy of how medicine is created” by combining generative biology and chemistry with AI-driven computational methods. ## Products & Services - **Hyperloop™ Platform**: An integrated drug discovery platform that merges structure-based drug discovery, machine learning, proprietary big data infrastructure, and experimental validation to generate candidate-ready small molecule compounds targeting GPCRs. (SaaS/internal tool – not sold externally) - **Pipeline – MC4R Agonist**: A selective, biased MC4R agonist advancing to IND-enabling studies for the treatment of obesity. - **Other pipeline programs**: Undisclosed GPCR targets for cardiometabolic diseases, developed in collaboration with Eli Lilly. ## Market Standing - **Valuation**: Not publicly available - **Key Metric**: Total funding raised – $158M (CB Insights estimate) - **Notable Investors/Partners**: Eli Lilly and Company (collaborator and equity investor), RA Capital Management, Insight Partners, Gaingels, NVentures (NVIDIA’s venture arm) - **Growth Signals**: - Announced a multi-target collaboration with Eli Lilly worth up to $1.3B in upfront, near-term, milestone payments, equity investment, and tiered royalties. - Biased MC4R agonist moving into IND-enabling studies. - Active hiring: 5+ open positions in Machine Learning, Protein Design, Computational Chemistry, HR, and Finance. ## Competitive Advantages - **Hyperloop Platform**: Combines deep biology/chemistry expertise with AI and proprietary big data in a single, rapid iteration cycle – enabling candidate-ready compounds at unprecedented speed. - **GPCR Focus**: Specialization in the most challenging GPCR targets, a proven class for drug development but historically difficult to modulate selectively. - **Big Pharma Backing**: Strategic collaboration with Eli Lilly provides significant funding, validation, and potential for rapid clinical development. ## Strategic Focus - Advance the MC4R agonist and other pipeline candidates through IND-enabling studies and into clinical trials. - Expand the Hyperloop platform’s application to additional GPCR targets and disease areas beyond cardiometabolic indications. - Leverage AI/ML and structural biology to compress traditional drug discovery timelines from years to months. ## Why Work Here - **Culture**: Core values emphasize urgency (speed to patients), resilience, collaboration, transparency, and compassion. The team describes the environment as inclusive, collaborative, and supportive. - **Work Policy**: Primarily onsite at a brand-new lab space in Boston’s Seaport area (Lilly Gateway Labs). Remote/hybrid flexibility is not explicitly stated. - **Benefits**: 100% employer-paid health/dental/vision insurance, equity participation, 401k, unlimited paid time off, and a subsidy for parking or mass transit. - **Engineering & Science Culture**: Opportunities to work at the intersection of AI/ML, computational chemistry, and structural biology in a well-funded, fast-moving biotech startup with direct pharma partnerships. ## Sources 1. [superluminalrx.com](https://www.superluminalrx.com/about/) 2. [superluminalrx.com](https://www.superluminalrx.com/careers/) 3. [cbinsights.com](https://www.cbinsights.com/company/superluminal-medicines) 4. [job-boards.greenhouse.io](https://job-boards.greenhouse.io/superluminalrx) ## Other roles at Superluminal Medicines, Inc. - [Sr. Scientist, In-Vivo Pharmacology](https://feeny.ai/job/sr-scientist-in-vivo-pharmacology-superluminal-medicines-inc-boston-t0xzfs92rdv8) — Boston, MA - [Scientist, Membrane Protein](https://feeny.ai/job/scientist-membrane-protein-superluminal-medicines-inc-boston-1xpt5v22wx42) — Boston, MA - [Research Associate, Discovery Biology](https://feeny.ai/job/research-associate-discovery-biology-superluminal-medicines-inc-boston-e0kb5bkcyks8) — Boston, MA - [Sr. Scientist / Principal Scientist, Computational Chemistry](https://feeny.ai/job/sr-scientist-principal-scientist-computational-chemistry-superluminal-medicines-amgvtc3fygv1) — Boston, MA